Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
US Army
Cipla
Argus Health
Boehringer Ingelheim
Teva
McKinsey
Merck
UBS

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,687,777

« Back to Dashboard

Summary for Patent: 4,687,777

Title: Thiazolidinedione derivatives, useful as antidiabetic agents
Abstract:Thiazolidinedione derivatives of the formula: ##STR1## and pharmacologically acceptable salts thereof are novel compounds, which exhibit in mammals blood sugar- and lipid-lowering activity, and are of value as a therapeutic agent for treatment of diabetes and hyperlipemia.
Inventor(s): Meguro; Kanji (Nishinomiya, JP), Fujita; Takeshi (Takarazuka, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:06/820,390
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,687,777

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan60-8085Jan 19, 1985

International Patent Family for Patent: 4,687,777

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Czechoslovakia9104079► Subscribe
Germany3662689► Subscribe
Germany10199018► Subscribe
Denmark21986► Subscribe
Denmark171614► Subscribe
European Patent Office0193256► SubscribeSPC/GB01/016United Kingdom► Subscribe
European Patent Office0193256► SubscribeC300038Netherlands► Subscribe
European Patent Office0193256► Subscribe2001C/011Belgium► Subscribe
Spain550986► Subscribe
Spain8705886► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Dow
Accenture
Deloitte
Daiichi Sankyo
Cantor Fitzgerald
Cipla
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot